Impact of COVID-19 on national surveillance of norovirus in England and potential risk of increased disease activity in 2021.

Douglas, A; Sandmann, F G; Allen, D J; Celma, C C; Beard, S; Larkin, L

Douglas, A; Sandmann, F G; Allen, D J; Celma, C C; Beard, S; Larkin, L.

Douglas A; Gastrointestinal Pathogens Unit, National Infection Service, Public Health England, London, UK. Electronic address: Amy.Douglas@phe.gov.uk.
Sandmann FG; Statistics, Modelling and Economics Department, National Infection Service, Public Health England, London, UK; Department of Infectious Disease Epidemiology and NIHR Health Protection Research Unit in Modelling and Health Economics, London School of Hygiene and Tropical Medicine, London, UK.
Allen DJ; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Celma CC; Enteric Virus Unit, National Infection Service Laboratories, Public Health England, London, UK.
Beard S; Enteric Virus Unit, National Infection Service Laboratories, Public Health England, London, UK.
Larkin L; Gastrointestinal Pathogens Unit, National Infection Service, Public Health England, London, UK.

J Hosp Infect ; 112: 124-126, 2021 06.

Article in English | MEDLINE | ID: covidwho-1131498

Subject(s)

COVID-19/epidemiology; Caliciviridae Infections/epidemiology; Epidemiological Monitoring; COVID-19/diagnosis; England/epidemiology; Humans; Norovirus/pathogenicity; Seasons

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Caliciviridae Infections / Epidemiological Monitoring / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: J Hosp Infect Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google